Puerto Rican chemical industry news

9 December 2025

Lilly to Invest $6 Billion in Alabama API Facility

The new facility in Huntsville will create 3,450 jobs, focus on small molecule and peptide medicines, and enhance supply chain resilience with advanced technologies. Completion expected by 2032.
30 October 2025

Lilly Q3 2025 Financials: Revenue Up 54%, R&D Progress, Guidance Raised

Revenue growth driven by incretin demand. Advanced orforglipron trials, FDA approval for Inluriyo. Expanded manufacturing in Virginia, Texas, Puerto Rico.
29 October 2025

Lilly Invests $1.2 Billion in Puerto Rico for U.S. Oral Medicine Manufacturing Expansion

The investment will create 100 manufacturing and 1,000 construction jobs, enhancing production of oral solid medicines with advanced technologies. Construction starts in 2026, production by 2028.

How does the Puerto Rican chemical industry perform?

Find out with chemXplore Analytics